Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide is an experimental small molecule compound belonging to the class of organic compounds known as carboxamides and specifically, the subclass of 2-furanilides. It features a furan ring substituted with bromo, chloro, and piperazine moieties. The compound has been cataloged in several chemical databases (DrugBank DB08021, PubChem CID 44224261, ChEMBL CHEMBL1233749), but there is no publicly available information on its mechanism of action, biological targets, or clinical development status. Its primary use appears to be in research settings rather than as an approved pharmaceutical agent[1][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide.